Choksi Laboratories Ltd

Choksi Laboratories Limited announced that its board of directors re-appointed Ms. Himika Choksi as a Whole Time Director for a further period of five years, effective April 1, 2027, subject to shareholder approval at the company's upcoming Annual General Meeting. Ms. Choksi, who is a Promoter member of the company, is the daughter of Managing Director Sunil Choksi and Whole Time Director Stela Choksi, and the sister of Whole Time Director Vyangesh Choksi.

Choksi Laboratories Limited announced the reappointment of M/s Tanmay V. Rajurkar & Co. as the Internal Auditor for the financial year 2026-27, effective August 13, 2026, to comply with the Companies Act, 2013 and the requirements under SEBI (LODR) Regulations, 2015.

Choksi Laboratories Limited will hold a meeting of its Board of Directors on August 13, 2026, at 02:30 P.M. to discuss the unaudited financial results for the quarter ended June 30, 2026, the appointment of an internal auditor for the financial year 2026-27, and matters relating to the ensuing Annual General Meeting. The trading window for dealing in the company's securities will open 48 hours after the declaration of the unaudited financial results, according to a filing with the BSE Limited.

Choksi Laboratories Limited informed the BSE Limited that it has transferred electronic connectivity with depositories, namely National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL), from MUFG Intime India Private Limited to Ankit Consultancy Private Limited, effective August 3, 2026. The company will execute a tripartite agreement with MUFG Intime India Private Limited and Ankit Consultancy Private Limited and will intimate the Stock exchanges within the statutory timelines.

Net profit of Choksi Laboratories rose 11.96% to Rs 1.03 crore in the quarter ended March 2026 as against Rs 0.92 crore during the previous quarter ended March 2025. Sales rose 12.46% to Rs 12.82 crore in the quarter ended March 2026 as against Rs 11.40 crore during the previous quarter ended March 2025. For the full year,net profit rose 28.95% to Rs 1.96 crore in the year ended March 2026 as against Rs 1.52 crore during the previous year ended March 2025. Sales rose 10.12% to Rs 46.01 crore in the year ended March 2026 as against Rs 41.78 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales12.8211.40 12 46.0141.78 10 OPM %28.3930.70 -26.3626.88 - PBDT2.992.96 1 9.538.65 10 PBT1.101.26 -13 2.442.15 13 NP1.030.92 12 1.961.52 29 Powered by Capital Market - Live

Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 25 May 2026.

Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 18 May 2026.

Net profit of Choksi Laboratories rose 181.82% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 0.11 crore during the previous quarter ended December 2024. Sales rose 4.24% to Rs 10.82 crore in the quarter ended December 2025 as against Rs 10.38 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales10.8210.38 4 OPM %24.3124.57 - PBDT1.951.87 4 PBT0.120.19 -37 NP0.310.11 182 Powered by Capital Market - Live

Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 7 February 2026.Powered by Capital Market - Live

Net profit of Choksi Laboratories rose 200.00% to Rs 0.24 crore in the quarter ended September 2025 as against Rs 0.08 crore during the previous quarter ended September 2024. Sales rose 20.09% to Rs 11.12 crore in the quarter ended September 2025 as against Rs 9.26 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales11.129.26 20 OPM %26.3525.49 - PBDT2.251.71 32 PBT0.560.10 460 NP0.240.08 200 Powered by Capital Market - Live